← All stocks

Embecta Corp.

EMBC Net buying
CIK 0001872789 #3523 in the set updated 17 Sep 2026
Bought (12 mo)
$557.95K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$36.97K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$36.97K
1 of 1 sales
Net
+$520.97K
+$520.97K against sales at will

By person

14 insiders · 5 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
HOMBACH ROBERT J.
Director
$223.85K (1)
+$223.85K
109,587
0.1934%
$643.82K
+292.7%
Kurdikar Devdatt
President and CEO
$140.94K (1)
+$140.94K
804,919
1.42%
$4.73M
+94.9%
Mann Jeffrey Z
Pres, Pharm Svc&Prod Mgmt, CLO
$99.80K (1)
+$99.80K
262,915
0.4640%
$1.54M
+117.3%
Elguicze Jacob
SVP and CFO
$93.36K (1)
+$93.36K
309,139
0.5456%
$1.82M
+118.4%
Morris Milton Mayo
Director
$36.97K (1)
−$36.97K
53,828
0.0950%
$316.24K
+102.8%
Curtis Shaun
SVP, Global Manuf./Sup. Chain
95,324
0.1682%
$560.03K
+104.6%
Melcher David F
Director
86,681
0.1530%
$509.25K
+87.5%
Casner Jean
Chief Human Resources Officer
85,915
0.1516%
$504.75K
+179.5%
Roth Anthony M.
VP, Chief Accounting Officer
78,833
0.1391%
$463.14K
+3,592%
Reidy Christopher R
Director
70,122
0.1238%
$411.97K
+109.7%
Pomeroy Claire
Director
66,127
0.1167%
$388.50K
+124.6%
Anderson Carrie L
Director
64,581
0.1140%
$379.41K
+131.5%
Prange Karen
Director
64,581
0.1140%
$379.41K
+131.5%
Albritton David
Director
39,743
0.0701%
$233.49K
+53.4%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,104,498
History held since 5 Apr 2022